| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 149.6 | 143.0 |
| Gross profit | 63.2 | 55.3 |
| Profit before tax | 38.2 | 19.7 |
| Net income | 17.8 | 13.7 |
| EPS (diluted, $ a share) | $0.61 | $0.46 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +29.7% |
|---|---|
| Revenue, year on year | +4.6% |
| Gross margin | 42.2% |
| Operating margin | 17.1% |
10-Q filed with the SEC, NYSE: CTS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Cts Corp: key numbers
- Share price
- $58.86Close, Nov 16
- Market cap
- $1.68B
- Shares outstanding
- 28.5MLatest SEC cover page
- Sector
- Manufacturing
- Industry
- Printed Circuit BoardsSIC 3672
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Cts Corp
All →Cts Investor Presentation
CTS Corporation filed a formal investor presentation dated October 2026 to be used in meetings with investors, analysts, and others during the fiscal year. The presentation outlines the company's strategy, financial position, and objectives across its transportation, industrial, aerospace, defense, and medical markets.
Cts Financial Results
CTS Corporation reported third-quarter 2026 sales of $149.6 million, a 5% increase year-over-year driven by strength in diversified end-markets. The company achieved record margins and raised its full-year 2026 guidance for both sales and adjusted EPS, citing disciplined execution and the strategic acquisition of Millar.
- Term
- Q3 2026
“CTS delivered another strong quarter, with sales increasing 5% year over year, driven by continued strength across our increasingly diversified portfolio. Diversified end-market sales grew 7% and now represent 60% of total sales, while Transportation sales also posted modest growth.”
Pratik Trivedi, CEO of CTS Corporation
“Our disciplined execution is delivering profitable growth, record margins and strong cash generation. The acquisition of Millar further advances our diversification strategy, especially in the medical end market, and enhances our opportunity to create sustainable long-term value.”
Pratik Trivedi, CEO of CTS Corporation